| Bacteriophage interactions with mammalian tissue: Therapeutic applications H Huh, S Wong, JS Jean, R Slavcev Advanced drug delivery reviews 145, 4-17, 2019 | 146 | 2019 |
| Advances in gene-based vaccine platforms to address the COVID-19 pandemic D Pushparajah, S Jimenez, S Wong, H Alattas, N Nafissi, RA Slavcev Advanced drug delivery reviews 170, 113-141, 2021 | 111 | 2021 |
| Bacteriophage lambda display systems: developments and applications J Nicastro, K Sheldon, RA Slavcev Applied microbiology and biotechnology 98, 2853-2866, 2014 | 77 | 2014 |
| Addressing the challenge: current and future directions in ovarian cancer therapy T Kaur, RA Slavcev, SD Wettig Current Gene Therapy 9 (6), 434-458, 2009 | 73 | 2009 |
| Immunocompatibility of bacteriophages as nanomedicines T Kaur, N Nafissi, O Wasfi, K Sheldon, S Wettig, R Slavcev Journal of nanotechnology 2012 (1), 247427, 2012 | 72 | 2012 |
| DNA ministrings: highly safe and effective gene delivery vectors N Nafissi, S Alqawlaq, EA Lee, M Foldvari, PA Spagnuolo, RA Slavcev Molecular Therapy-Nucleic Acids 3, 2014 | 51 | 2014 |
| Partition systems of bacterial plasmids BE Funnell, RA Slavcev Plasmid Biology, 79-103, 2004 | 48 | 2004 |
| Bacteriophage recombination systems and biotechnical applications N Nafissi, R Slavcev Applied microbiology and biotechnology 98, 2841-2851, 2014 | 47 | 2014 |
| Stationary phase-like properties of the bacteriophage λ Rex exclusion phenotype RA Slavcev, S Hayes Molecular Genetics and Genomics 269 (1), 40-48, 2003 | 41 | 2003 |
| Construction and Characterization of an in-vivo Linear Covalently Closed DNA Vector Production System N Nafissi, R Slavcev Microbial cell factories 11, 1-13, 2012 | 36 | 2012 |
| Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice A Razazan, J Nicastro, R Slavcev, N Barati, A Arab, F Mosaffa, MR Jaafari, ... Scientific reports 9 (1), 2221, 2019 | 35 | 2019 |
| Solid lipid nanoparticles: tuneable anti-cancer gene/drug delivery systems T Kaur, R Slavcev In. Tech, 53-73, 2013 | 35 | 2013 |
| Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response A Arab, J Nicastro, R Slavcev, A Razazan, N Barati, AR Nikpoor, ... Immunologic research 66, 200-206, 2018 | 34 | 2018 |
| The viral approach to breast cancer immunotherapy A Arab, N Behravan, A Razazn, N Barati, F Mosaffa, J Nicastro, R Slavcev, ... Journal of Cellular Physiology 234 (2), 1257-1267, 2019 | 33 | 2019 |
| Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice N Barati, A Razazan, J Nicastro, R Slavcev, A Arab, F Mosaffa, ... Cancer letters 424, 109-116, 2018 | 31 | 2018 |
| Impact of DNA vector topology on non-viral gene therapeutic safety and efficacy C H. Sum, S Wettig, R A. Slavcev Current gene therapy 14 (4), 309-329, 2014 | 29 | 2014 |
| Thermodynamic investigation of the binding of dissymmetric pyrenyl-gemini surfactants to DNA SD Wettig, R Deubry, J Akbar, T Kaur, H Wang, T Sheinin, JW Joseph, ... Physical Chemistry Chemical Physics 12 (18), 4821-4826, 2010 | 29 | 2010 |
| Treating cancer with infection: a review on bacterial cancer therapy S Wong, RA Slavcev Letters in applied microbiology 61 (2), 107-112, 2015 | 23 | 2015 |
| Bacteriophage applications-historical perspective and future potential J Nicastro, S Wong, Z Khazaei, P Lam, J Blay, RA Slavcev Springer International Publishing, 2016 | 22 | 2016 |
| Construction and analysis of a genetically tuneable lytic phage display system J Nicastro, K Sheldon, FA El-Zarkout, S Sokolenko, MG Aucoin, R Slavcev Applied microbiology and biotechnology 97, 7791-7804, 2013 | 20 | 2013 |
Jessica NicastroUniversity of Waterloo在 uwaterloo.ca 的电子邮件经过验证
Jessica NicastroUniversity of Waterloo在 uwaterloo.ca 的电子邮件经过验证